NO840244L - Fremgangsmaate for fremstilling av aminerte derivater av pyridazin. - Google Patents
Fremgangsmaate for fremstilling av aminerte derivater av pyridazin.Info
- Publication number
- NO840244L NO840244L NO840244A NO840244A NO840244L NO 840244 L NO840244 L NO 840244L NO 840244 A NO840244 A NO 840244A NO 840244 A NO840244 A NO 840244A NO 840244 L NO840244 L NO 840244L
- Authority
- NO
- Norway
- Prior art keywords
- pyridazine
- thienyl
- methyl
- formula
- amine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8301029A FR2539742B1 (fr) | 1983-01-24 | 1983-01-24 | Derives amines de la pyridazine substitues en position 6 par un heterocycle ou un alicycle, lesdits derives etant actifs sur le systeme nerveux central |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO840244L true NO840244L (no) | 1984-07-25 |
Family
ID=9285222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO840244A NO840244L (no) | 1983-01-24 | 1984-01-23 | Fremgangsmaate for fremstilling av aminerte derivater av pyridazin. |
Country Status (24)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3876245D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1987-08-19 | 1993-01-07 | Rwe Entsorgung Ag, 4300 Essen, De | |
| FR2665442B1 (fr) * | 1990-07-31 | 1992-12-04 | Sanofi Sa | Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant. |
| US5631255A (en) * | 1989-02-07 | 1997-05-20 | Sanofi | Pyridazine derivatives |
| PT93060B (pt) | 1989-02-07 | 1995-12-29 | Sanofi Sa | Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem |
| US5461053A (en) * | 1989-02-07 | 1995-10-24 | Sanofi | Pyridazine derivatives |
| AU2005260102A1 (en) * | 2004-05-08 | 2006-01-12 | Novartis International Pharmaceutical Ltd. | 3-aryl-5,6-disubstituted pyridazines |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1292443A (en) * | 1968-11-01 | 1972-10-11 | Ct D Etudes Experimentales Et | New pyridazine derivatives and process for their preparation |
| GB1345880A (en) * | 1971-06-18 | 1974-02-06 | Cepbepe | Pyridazine derivatives |
-
1983
- 1983-01-24 FR FR8301029A patent/FR2539742B1/fr not_active Expired
-
1984
- 1984-01-18 EP EP84400102A patent/EP0117171B1/fr not_active Expired
- 1984-01-18 CA CA000445483A patent/CA1218063A/en not_active Expired
- 1984-01-18 DE DE8484400102T patent/DE3464491D1/de not_active Expired
- 1984-01-18 US US06/571,698 patent/US4524070A/en not_active Expired - Fee Related
- 1984-01-18 AT AT84400102T patent/ATE28077T1/de active
- 1984-01-19 ES ES529007A patent/ES8407043A1/es not_active Expired
- 1984-01-20 PT PT77982A patent/PT77982B/pt not_active IP Right Cessation
- 1984-01-20 NZ NZ206907A patent/NZ206907A/en unknown
- 1984-01-23 ZA ZA84501A patent/ZA84501B/xx unknown
- 1984-01-23 KR KR1019840000274A patent/KR910000641B1/ko not_active Expired
- 1984-01-23 SU SU843694357A patent/SU1189345A3/ru active
- 1984-01-23 IL IL70757A patent/IL70757A/xx unknown
- 1984-01-23 NO NO840244A patent/NO840244L/no unknown
- 1984-01-23 GR GR73585A patent/GR81717B/el unknown
- 1984-01-23 IE IE840150A patent/IE840150L/xx unknown
- 1984-01-23 DD DD84259545A patent/DD238793A5/de unknown
- 1984-01-23 FI FI840268A patent/FI840268A7/fi not_active Application Discontinuation
- 1984-01-24 YU YU00123/84A patent/YU12384A/xx unknown
- 1984-01-24 DK DK31584A patent/DK31584A/da unknown
- 1984-01-24 AU AU23727/84A patent/AU560542B2/en not_active Ceased
- 1984-01-24 HU HU84294A patent/HU192390B/hu unknown
- 1984-01-24 JP JP59010903A patent/JPS59139367A/ja active Pending
- 1984-01-24 CS CS84530A patent/CS241539B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK31584A (da) | 1984-07-25 |
| GR81717B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-12-12 |
| KR840007409A (ko) | 1984-12-07 |
| EP0117171B1 (fr) | 1987-07-01 |
| PT77982A (fr) | 1984-02-01 |
| IL70757A0 (en) | 1984-04-30 |
| FR2539742B1 (fr) | 1986-09-05 |
| ATE28077T1 (de) | 1987-07-15 |
| ES529007A0 (es) | 1984-09-01 |
| US4524070A (en) | 1985-06-18 |
| YU12384A (en) | 1986-10-31 |
| CS241539B2 (en) | 1986-03-13 |
| JPS59139367A (ja) | 1984-08-10 |
| SU1189345A3 (ru) | 1985-10-30 |
| AU2372784A (en) | 1984-07-26 |
| FI840268A0 (fi) | 1984-01-23 |
| FR2539742A1 (fr) | 1984-07-27 |
| CA1218063A (en) | 1987-02-17 |
| DK31584D0 (da) | 1984-01-24 |
| IL70757A (en) | 1986-12-31 |
| EP0117171A1 (fr) | 1984-08-29 |
| HU192390B (en) | 1987-06-29 |
| ES8407043A1 (es) | 1984-09-01 |
| ZA84501B (en) | 1984-09-26 |
| AU560542B2 (en) | 1987-04-09 |
| CS53084A2 (en) | 1985-07-16 |
| NZ206907A (en) | 1987-03-31 |
| DD238793A5 (de) | 1986-09-03 |
| DE3464491D1 (en) | 1987-08-06 |
| FI840268A7 (fi) | 1984-07-25 |
| KR910000641B1 (ko) | 1991-01-31 |
| IE840150L (en) | 1984-07-24 |
| PT77982B (fr) | 1986-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU1442077A3 (ru) | Способ получени замещенных андроста-1,4-диен-3,17-дионов | |
| EP0820441B1 (en) | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS | |
| Ferrarini et al. | Synthesis and β-blocking activity of (R, S)-(E)-oximeethers of 2, 3-dihydro-1, 8-naphthyridine and 2, 3-dihydrothiopyrano [2, 3-b] pyridine: potential antihypertensive agents–Part IX | |
| TW200817358A (en) | Pyridin-3-yl derivatives | |
| IL123581A (en) | History of pyrimidine as receptor antagonists - 5HT2C, the process for their preparation and drugs containing them | |
| CN101848909A (zh) | 可用作蛋白激酶抑制剂的吡咯并[3,2-c]吡啶 | |
| JPH09510223A (ja) | 複素環式化合物、その調製及び使用 | |
| RU2007393C1 (ru) | Способ получения тетрагидробенз (c,d)индоловых агонистов серотонина | |
| NO159272B (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive dihydropyridiner. | |
| JPH11508540A (ja) | 新規の置換アザ環式またはアザ二環式化合物 | |
| NO840244L (no) | Fremgangsmaate for fremstilling av aminerte derivater av pyridazin. | |
| JPH09511238A (ja) | α−拮抗活性を有するキナゾリニル−アミノ誘導体 | |
| NO159170B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazin-forbindelser. | |
| KR100921214B1 (ko) | 4-(티오- 또는 셀레노잔텐-9-일리덴)-피페리딘 또는아크리딘 유도체 및 선택적 5-ｈｔ2ｂ 수용체 길항제로사용하기 위한 이들의 용도 | |
| KR100355170B1 (ko) | 20위치에아미노치환사슬이있는신규한스테로이드,그의제조방법및중간체,의약의로서의용도,및그를함유하는조성물 | |
| FI80272C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrazolderivat med ergolinskelett samt deras syraadditionssalter. | |
| WO2024120426A1 (zh) | 一种甲状腺激素β受体激动剂、晶型、制备方法和用途 | |
| EP1802572A1 (de) | Indol derivative als inhibitoren der löslichen adenylatzyklase | |
| US4104385A (en) | Cyclic alkylidenyl N-[6-(amino)-3-pyridazinyl]aminomethylenemalonates | |
| KR20090007351A (ko) | 가용성 아데닐레이트 시클라제 억제제 | |
| JPH02240070A (ja) | ５―アルキルピリダジン誘導体及びその用途 | |
| JP2514812B2 (ja) | ３−（１Ｈ−テトラゾ−ル−５− イル） チエノ〔２，３−ｄ〕 ピリミジン−４（３Ｈ）−オン類 | |
| CH618963A5 (en) | Process for the preparation of oxanilic acid derivatives | |
| EP2001843A2 (de) | Inhibitoren der löslichen adenylatzyklase | |
| JP2002255937A (ja) | 新規化合物 |